DR. CARL M. MENDEL, M.D.
Osteopathic Medicine at Great Hills Ter, Short Hills, NJ
License number
New Jersey 25MA05866100
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
8 Great Hills Ter, Short Hills, NJ 07078
Phone
(973) 467-0930
Professional information
Treatment Of Gallstones
US Patent:
6376552, Apr 23, 2002
Filed:
Mar 17, 2000
Appl. No.:
09/527962
Inventors:
Carl M. Mendel - Short Hills NJ
Timothy B. Seaton - Far Hills NJ
Steve P. Weinstein - Hartsdale NY
Timothy B. Seaton - Far Hills NJ
Steve P. Weinstein - Hartsdale NY
Assignee:
Knoll Pharmaceutical Company - Mount Olive NJ
International Classification:
A61K 3122
US Classification:
514646
Abstract:
A compound of formula I or a pharmaceutically acceptable salt thereof in which R and R are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for treating gallstones, particularly gallstones associated with weight loss or associated with gall bladder disease related to obesity.
Treatment Of Menstrual Function
US Patent:
6372797, Apr 16, 2002
Filed:
Mar 17, 2000
Appl. No.:
09/527811
Inventors:
Carl M. Mendel - Short Hills NJ
Timothy B. Seaton - Far Hills NJ
Steve P. Weinstein - Hartsdale NY
Timothy B. Seaton - Far Hills NJ
Steve P. Weinstein - Hartsdale NY
Assignee:
Knoll Pharmaceutical Company - Mount Olive NJ
International Classification:
A61K 31135
US Classification:
514646, 514899
Abstract:
A compound of formula I or a pharmaceutically acceptable salt thereof in which R and R are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for treating menstrual function and infertility.
Treatment Of Hyperactivity Disorders
US Patent:
6372798, Apr 16, 2002
Filed:
Mar 17, 2000
Appl. No.:
09/528046
Inventors:
Carl M. Mendel - Short Hills NJ
Timothy B. Seaton - Far Hills NJ
Steve P. Weinstein - Hartsdale NY
Timothy B. Seaton - Far Hills NJ
Steve P. Weinstein - Hartsdale NY
Assignee:
Knoll Pharmaceutical Company - Mount Olive NJ
International Classification:
A61K 3122
US Classification:
514646
Abstract:
A compound of formula I or a pharmaceutically acceptable salt thereof in which R and R are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for treating hyperactivity disorders, such as attention deficit hyperactivity disorder and hyperkinetic disorder.
Treatment Of Pharmacology Of Drug Misuse And Other Addictive Disorders
US Patent:
6346549, Feb 12, 2002
Filed:
Mar 17, 2000
Appl. No.:
09/527726
Inventors:
Carl M. Mendel - Short Hills NJ
Timothy B. Seaton - Far Hills NJ
Steve P. Weinstein - Hartsdale NY
Timothy B. Seaton - Far Hills NJ
Steve P. Weinstein - Hartsdale NY
Assignee:
Knoll Pharmaceutical Company - Mt. Olive NJ
International Classification:
A61K 31135
US Classification:
514646
Abstract:
A compound of formula I or a pharmaceutically acceptable salt thereof in which R and R are independently H or methyl (for example , -dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for treating disorders arising from drug misuse or other addictive disorders.
Prevention Or Treatment Of Insomnia With A Neurokinin-1 Receptor Antagonist
US Patent:
6525073, Feb 25, 2003
Filed:
Oct 16, 2001
Appl. No.:
09/978292
Inventors:
Carl M. Mendel - Short Hills NJ
Joanne Waldstreicher - Scotch Plains NJ
Joanne Waldstreicher - Scotch Plains NJ
Assignee:
Merck Co. Inc. - Rahway NJ
International Classification:
A61K 3136
US Classification:
514337, 514364, 514381
Abstract:
A tachykinin antagonist is useful, alone or in conjunction with other agents, for altering circadian rhythmicity and alleviating circadian rhythm disorders and for enhancing and improving the quality of sleep.
Treatment Of Neuropathic Pain Or Fibromyalgia
US Patent:
6803387, Oct 12, 2004
Filed:
Mar 17, 2000
Appl. No.:
09/528798
Inventors:
Carl M. Mendel - Short Hills NJ
Timothy B. Seaton - Far Hills NJ
Steve P. Weinstein - Hartsdale NY
Edward Chong - Nottingham, GB
Timothy B. Seaton - Far Hills NJ
Steve P. Weinstein - Hartsdale NY
Edward Chong - Nottingham, GB
Assignee:
Abbott GmbH Co. KG - Wiesbaden
International Classification:
A61K 31135
US Classification:
514646
Abstract:
A compound of formula I or a pharmaceutically acceptable salt thereof in which R and R are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl) cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for treating fibromyalgia or neuropathic pain, such as pain associated with diabetes mellitus, shingles, nerve injury and varied peripheral neuropathies.
Treatment Of Chronic Fatigue Syndrome
US Patent:
6376551, Apr 23, 2002
Filed:
Mar 17, 2000
Appl. No.:
09/527812
Inventors:
Carl M. Mendel - Short Hills NJ
Timothy B. Seaton - Far Hills NJ
Steve P. Weinstein - Hartsdale NY
Timothy B. Seaton - Far Hills NJ
Steve P. Weinstein - Hartsdale NY
Assignee:
Knoll Pharmaceutical Company - Mount Olive NJ
International Classification:
A61K 3122
US Classification:
514646
Abstract:
A compound of formula I or a pharmaceutically acceptable salt thereof in which R and R are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for treating chronic fatigue syndrome.
Treatment Of Premenstrual Syndrome
US Patent:
2002013, Sep 19, 2002
Filed:
Mar 17, 2000
Appl. No.:
09/528047
Inventors:
Carl Mendel - Short Hills NJ, US
Timothy Seaton - Far Hills NJ, US
Steve Weinstein - Hartsdale NY, US
Timothy Seaton - Far Hills NJ, US
Steve Weinstein - Hartsdale NY, US
International Classification:
A61K031/47, A61K031/135
US Classification:
514/646000
Abstract:
A compound of formula I
or a pharmaceutically acceptable salt thereof in which Rand Rare independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for treating premenstrual syndrome.
Enhancement Of Sleep With A Tachykinin Antagonist
US Patent:
6329401, Dec 11, 2001
Filed:
Dec 16, 1999
Appl. No.:
9/464972
Inventors:
Carl M. Mendel - Short Hills NJ
Joanne Waldstreicher - Scotch Plains NJ
Joanne Waldstreicher - Scotch Plains NJ
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 3136
US Classification:
514337
Abstract:
A tachykinin antagonist is useful, alone or in conjunction with other agents, for altering circadian rhythmicity and alleviating circadian rhythm disorders and for enhancing and improving the quality of sleep.
Treatment Of Osteoarthritis
US Patent:
6232347, May 15, 2001
Filed:
Mar 17, 2000
Appl. No.:
9/528291
Inventors:
Carl M. Mendel - Short Hills NJ
Timothy B. Seaton - Far Hills NJ
Steve P. Weinstein - Hartsdale NY
Timothy B. Seaton - Far Hills NJ
Steve P. Weinstein - Hartsdale NY
Assignee:
Knoll Pharmaceutical Company - Mount Olive NJ
International Classification:
A61K 31135
US Classification:
514646
Abstract:
A compound of formula I ##STR1##
or a pharmaceutically acceptable salt thereof in which R. sub. 1 and R. sub. 2 are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for treating osteoarthritis or gout.